The ShorTrip trial found that short-course radiotherapy followed by FOLFOX and FOLFOXIRI improved pathological response rates ...

Terence M. Williams, MD, PhD, discussed the phase 1 DINOMITE trial of radiation therapy and papaverine in rectal cancer at ...

Oncology specialists from UC San Francisco will present new clinical research findings and cutting-edge treatment strategies at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, ...

Patients with pathologic complete response after neoadjuvant ... breast cancer. Participants also underwent image-guided vacuum assisted biopsy (VAB) of the tumor bed after chemotherapy.

Most often, neoadjuvant chemotherapy is administered before surgery to improve the chances of removing all your cancer cells. It may also allow doctors to perform less extensive surgery than they ...

A total neoadjuvant therapy (TNT) approach is strongly recommended for patients with T3 to T4 and node-positive rectal cancer ...

as known as total neoadjuvant therapy (TNT). “Watch-and-wait is becoming the new standard of care for some patients with locally advanced rectal cancer,” said Zhao. “Combining chemotherapy and ...

Neoadjuvant chemotherapy followed by radical cystectomy is the standard treatment for cisplatin-eligible patients with muscle-invasive bladder cancer. Adding perioperative immunotherapy may ...

Toxicity was observed during radiotherapy and chemotherapy ... NAR (short for neoadjuvant rectal cancer) scores, and pathological staging. Fewer sensory problems were reported compared to previous ...

Locally advanced rectal cancer has traditionally been treated with a combination of radiotherapy and chemotherapy, followed by surgery and further chemotherapy. Four years ago, a randomised study ...